Depósito Digital de Documentos de la UAB Encontrados 1 registros  La búsqueda tardó 0.00 segundos. 
1.
6 p, 488.2 KB Effect of Nintedanib on Lung Function in Patients With Systemic Sclerosis−Associated Interstitial Lung Disease : Further Analyses of a Randomized, Double-Blind, Placebo-Controlled Trial / Maher, Toby M. (National Heart and Lung Institute. Imperial College London and NIHR Clinical Research Facility. Royal Brompton Hospital. London. UK. and Keck School of Medicine. University of Southern California) ; Mayes, Maureen D. (University of Texas McGovern Medical School) ; Kreuter, Micahel (Thoraxklinik. University of Heidelberg. and the German Center for Lung Research) ; Volkmann, Elizabeth R. (University of California. David Geffen School of Medicine) ; Aringer, Martin (University Medical Center and Faculty of Medicine Carl Gustav Carus. TU Dresden) ; Castellvi, Ivan (Institut d'Investigació Biomèdica Sant Pau) ; Cutolo, Maurizio (Istituto di Ricovero e Cura A Carattere Scientifico (IRCCS)) ; Stock, Christian (Boehringer Ingelheim Pharma GmbH & Co. KG) ; Schoof, Nils (Boehringer Ingelheim International GmbH. Ingelheim am Rhein) ; Alves, Margarida (Boehringer Ingelheim International GmbH. Ingelheim am Rhein) ; Raghu, Ganesh (University of Washington)
Objective: In the SENSCIS trial in subjects with systemic sclerosis-associated interstitial lung disease (SSc-ILD), nintedanib reduced the rate of decline in forced vital capacity (FVC) over 52 weeks by 44% versus placebo. [...]
2021 - 10.1002/art.41576
Arthritis and Rheumatology, Vol. 73 Núm. 4 (april 2021) , p. 671-676  

Vea también: autores con nombres similares
1 Stock, C.A.
4 Stock, Charles
1 Stock, Charles A.
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.